These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1866922)

  • 21. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality of blood sugar control and late complications of diabetes].
    Sélam JL
    Rev Med Suisse Romande; 1995 Sep; 115(9):653-7. PubMed ID: 7481350
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prostacyclin-like activity modifying plasma factors in diabetic microangiopathy].
    Magyari M; Túri S; Csanálosi-Németh M
    Fortschr Ophthalmol; 1990; 87(3):269-73. PubMed ID: 2115854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease.
    Elias AN; Eng S
    Diabetes Obes Metab; 2005 Mar; 7(2):117-21. PubMed ID: 15715884
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
    Melosi A; Ricci F
    Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The results of a comparative study of the lipid peroxidation processes and of the malondialdehyde level of the blood cells in patients with diabetic angiopathies and during insulin therapy].
    Rud'ko IA; Balashova TS; Golega EN; Balabolkin MI; Kubatiev AA
    Ter Arkh; 1994; 66(10):27-9. PubMed ID: 7863440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum hexosamines in diabetic angiopathies].
    Riabchuk OG; Kliachko VR; Tirkina TN; Starosel'tseva LK
    Probl Endokrinol (Mosk); 1970; 16(6):14-6. PubMed ID: 5521085
    [No Abstract]   [Full Text] [Related]  

  • 31. [Plasma Lp(a) levels: a comparison between diabetic and nondiabetic patients with the nephrotic syndrome and control subjects].
    Postorino G; Altavilla R; Turchetti V; De Matteis C; Leoncini F; Picciolini F; Guerrini M; Forconi S
    Recenti Prog Med; 1995 Feb; 86(2):53-6. PubMed ID: 7754172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood coagulation disorders in patients with chronic calculous pyelonephritis and diabetes mellitus].
    Bachurin VI
    Vrach Delo; 1985 Aug; (8):89-92. PubMed ID: 4072119
    [No Abstract]   [Full Text] [Related]  

  • 33. Abnormal hemorheology in diabetes mellitus.
    Barnes A; Locke P; Dormandy J; Dormandy T
    Bibl Anat; 1977; (16 Pt 2):428-9. PubMed ID: 603576
    [No Abstract]   [Full Text] [Related]  

  • 34. [Some alterations of blood coagulation, fibrinolysis and nail fold microcirculation in diabetes mellitus complications (author's transl)].
    Chi ZS
    Zhonghua Nei Ke Za Zhi; 1980 Apr; 19(4):247-51. PubMed ID: 7428516
    [No Abstract]   [Full Text] [Related]  

  • 35. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
    Cucuianu M; Fekete T; Marcusiu C; Mösler R; Duţu A
    Med Interne; 1984; 22(3):171-7. PubMed ID: 6494764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
    Udvardy M; Pósán E
    Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
    Faur L; Motocu M; Moldovan C; Onaca M; Muţiu G
    Rom J Morphol Embryol; 2005; 46(4):307-9. PubMed ID: 16688368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interrelation of alpha-cholesterol and triglycerides in the blood of diabetic patients with and without ischemic heart disease].
    Slavina LS; Kudriakova SV; Romanovskaia GA; Mazovetskiĭ AG; Kantardzhian IG
    Ter Arkh; 1984; 56(10):98-101. PubMed ID: 6523369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study on nephropathy in type 2 diabetes mellitus: histology and its correlation with clinical and biochemical parameters.
    Bhattacharya S; Mandal SK; Bandyopadhyay R; Chakrabarti S; Basu AK; Pal S
    J Indian Med Assoc; 2007 Oct; 105(10):592, 594-6. PubMed ID: 18383954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.